Cargando…

Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer

New therapies are needed to improve the low survival rates of patients with metastatic colon cancer. Evidence suggests that amino acid (AA) restriction can be used to target the altered metabolism of cancer cells. In this work, we evaluated the therapeutic potential of selective AA restriction in co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiménez-Alonso, Julio José, Guillén-Mancina, Emilio, Calderón-Montaño, José Manuel, Jiménez-González, Víctor, Díaz-Ortega, Patricia, Burgos-Morón, Estefanía, López-Lázaro, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412877/ https://www.ncbi.nlm.nih.gov/pubmed/36014884 http://dx.doi.org/10.3390/nu14163378

Ejemplares similares

Artificial Diets with Selective Restriction of Amino Acids and Very Low Levels of Lipids Induce Anticancer Activity in Mice with Metastatic Triple-Negative Breast Cancer
por: Guillén-Mancina, Emilio, et al.
Publicado: (2023)

Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma
por: Jiménez-Alonso, Julio José, et al.
Publicado: (2023)

Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma
por: Calderón-Montaño, José Manuel, et al.
Publicado: (2022)

Screening for Selective Anticancer Activity of 65 Extracts of Plants Collected in Western Andalusia, Spain
por: Calderón-Montaño, José Manuel, et al.
Publicado: (2021)

Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid
por: Burgos-Morón, Estefanía, et al.
Publicado: (2016)

Dietary Manipulation of Amino Acids for Cancer Therapy
por: Jiménez-Alonso, Julio José, et al.
Publicado: (2023)

In Vitro Anticancer Activity and Mechanism of Action of an Aziridinyl Galactopyranoside
por: Burgos-Morón, Estefanía, et al.
Publicado: (2021)

Evaluating the Cancer Therapeutic Potential of Cardiac Glycosides
por: Calderón-Montaño, José Manuel, et al.
Publicado: (2014)

Comment on ‘Quiescence and γH2AX in neuroblastoma are regulated by Ouabain/Na,K-ATPase': ouabain and cancer
por: Calderón-Montaño, J M, et al.
Publicado: (2013)

5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair
por: Orta, Manuel Luís, et al.
Publicado: (2013)

The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions
por: Orta, Manuel Luis, et al.
Publicado: (2014)

Evaluation of Anticancer Activity of 76 Plant Species Collected in Andalusia (Spain) against Lung Cancer Cells
por: Jiménez-González, Víctor, et al.
Publicado: (2023)

The Cockayne syndrome protein B is involved in the repair of 5-AZA-2′-deoxycytidine-induced DNA lesions
por: Burgos-Morón, Estefanía, et al.
Publicado: (2018)

Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity
por: Recio, Rocío, et al.
Publicado: (2021)

Use of capecitabine in management of early colon cancer
por: Hameed, H, et al.
Publicado: (2011)

Clinical Management of Localized Colon Cancer with Capecitabine
por: Quidde, J., et al.
Publicado: (2012)

Comment on ‘Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer’
por: Molina-Garrido, M J, et al.
Publicado: (2011)

Compound Capecitabine Colon-Targeted Microparticle Prepared by Coaxial Electrospray for Treatment of Colon Tumors
por: Chen, Ruiqi, et al.
Publicado: (2022)

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Cessation or dose reduction of Capecitabine due to Complications in Patients with Colon Cancer
por: Sohn, Seung Kook
Publicado: (2010)

Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Capecitabine in the treatment of metastatic renal cell carcinoma
por: Oevermann, K, et al.
Publicado: (2000)

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
por: Wist, E. A., et al.
Publicado: (2012)

Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006)

Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer
por: Yun, Jung-A, et al.
Publicado: (2010)

Long-term survival of an elderly female with metastatic colon cancer after treated with capecitabine monotherapy: A case report
por: Liu, Jin, et al.
Publicado: (2019)

Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma
por: Larson, Kristian, et al.
Publicado: (2018)

Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction
por: Dicks, Matthew D. J., et al.
Publicado: (2018)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients
por: LIANG, XU, et al.
Publicado: (2015)

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer
por: Ren, Lanqi, et al.
Publicado: (2023)

Capecitabine-induced Leukoencephalopathy
por: Yoshimura, Kenji, et al.
Publicado: (2018)

Capecitabine-Induced Enterocolitis
por: Khan, Muzammil, et al.
Publicado: (2022)

Selective amino acid restriction therapy (SAART): a non-pharmacological strategy against all types of cancer cells
por: López-Lázaro, Miguel
Publicado: (2015)

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
por: Park, Se Hoon, et al.
Publicado: (2006)

Role of capecitabine in treating metastatic colorectal cancer in Chinese patients
por: Wang, Feng, et al.
Publicado: (2014)

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
por: Si, W., et al.
Publicado: (2013)

Amino acid metabolic reprogramming in tumor metastatic colonization
por: Wang, Zihao, et al.
Publicado: (2023)

Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer
por: Saura, Cristina, et al.
Publicado: (2021)

Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients
por: Matevska-Geshkovska, Nadica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cgb8sc7la6jl0kdl4i9obffdli